Donor-Derived CMV-Specific T Cells Reduce the Requirement for CMV-Directed Pharmacotherapy After Allogeneic Stem Cell Transplantation
Impact of Donor CMV Status on Viral Infection and Reconstitution of Multifunction CMV-Specific T Cells in CMV-Positive Transplant Recipients
Linking CMV Serostatus to Episodes of CMV Reactivation Following Lung Transplantation by Measuring CMV-Specific CD8+ T-Cell Immunity
CMV
Patients With Refractory Cytomegalovirus (CMV) Infection Following Allogeneic Haematopoietic Stem Cell Transplantation Are at High Risk for CMV Disease and Non-Relapse Mortality
Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
Chronic CMV Infection in Older Women: Longitudinal Comparisons of CMV DNA in Peripheral Monocytes, Anti-CMV IgG Titers, Serum IL-6 Levels, and CMV pp65 (NLV)-Specific CD8+ T-Cell Frequencies With Twelve Year Follow-Up
Priorities for CMV Vaccine Development
